Prognostic significance of the systemic immune-inflammation index in pancreatic carcinoma patients: a meta-analysis | Zendy

Xiaocheng Li | Zendy; Huapeng Lin | Zendy; Renbin Ouyang | Zendy; Yaowei Yang | Zendy; Jing Peng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prognostic significance of the systemic immune-inflammation index in pancreatic carcinoma patients: a meta-analysis

Author(s) -

Xiaocheng Li,

Huapeng Lin,

Renbin Ouyang,

Yaowei Yang,

Jing Peng

Publication year - 2021

Publication title -

bioscience reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.938

H-Index - 77

eISSN - 1573-4935

pISSN - 0144-8463

DOI - 10.1042/bsr20204401

Subject(s) - medicine , hazard ratio , oncology , pancreatic cancer , meta analysis , confidence interval , carcinoma , subgroup analysis , pancreatic carcinoma , stage (stratigraphy) , cancer , gastroenterology , paleontology , biology

Systemic immune-inflammation index (SII) is a prognostic indicator for several malignancies, including pancreatic carcinoma; however, there is no consensus on its significance. In the current study, a systematic meta-analysis was used to explore the correlation between SII and prognosis in pancreatic carcinoma patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research